Ellen N Kersh

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. doi request reprint Evaluation of the lymphocyte trafficking drug FTY720 in SHIVSF162P3-infected rhesus macaques
    Ellen N Kersh
    Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Antimicrob Chemother 63:758-62. 2009
  2. doi request reprint Repeated rectal SHIVSF162P3 exposures do not consistently induce sustained T cell responses prior to systemic infection in the repeat-low dose preclinical macaque model
    Ellen N Kersh
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    AIDS Res Hum Retroviruses 25:905-17. 2009
  3. pmc Reduced inflammation and CD4 loss in acute SHIV infection during oral pre-exposure prophylaxis
    Ellen N Kersh
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Infect Dis 206:770-9. 2012
  4. pmc Susceptibility to repeated, low-dose, rectal SHIVSF162P3 challenge is independent of TRIM5 genotype in rhesus macaques
    Katherine Butler
    Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    AIDS Res Hum Retroviruses 29:1091-4. 2013
  5. doi request reprint Resistance to Simian HIV infection is associated with high plasma interleukin-8, RANTES and Eotaxin in a macaque model of repeated virus challenges
    Nattawan Promadej-Lanier
    From the Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Acquir Immune Defic Syndr 53:574-81. 2010
  6. doi request reprint Short communication: no evidence of occult SHIV infection as demonstrated by CD8+ cell depletion after chemoprophylaxis-induced protection from mucosal infection in rhesus macaques
    Ellen N Kersh
    Division of HIV AIDS Prevention, NCHHSTP, CCID, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    AIDS Res Hum Retroviruses 24:543-6. 2008
  7. pmc T cell chemo-vaccination effects after repeated mucosal SHIV exposures and oral pre-exposure prophylaxis
    Ellen N Kersh
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
    PLoS ONE 6:e19295. 2011
  8. doi request reprint High susceptibility to repeated, low-dose, vaginal SHIV exposure late in the luteal phase of the menstrual cycle of pigtail macaques
    Sundaram A Vishwanathan
    Division of HIV AIDS Prevention, CDC, Atlanta, GA 30329, USA
    J Acquir Immune Defic Syndr 57:261-4. 2011

Collaborators

  • J Gerardo Garcia-Lerma
  • Walid Heneine
  • Dennis Ellenberger
  • Sunita Sharma
  • Katherine Butler
  • R Michael Hendry
  • Debra L Hanson
  • Sundaram A Vishwanathan
  • Debra R Adams
  • Ron A Otten
  • Patricia C Guenthner
  • Nattawan Promadej-Lanier
  • Debra Adams
  • Welkin E Johnson
  • Janet McNicholl
  • Jennifer S Morgan
  • Janet M McNicholl
  • Carol Y Lin
  • Charles Dobard
  • Wei Luo
  • Priya Srinivasan
  • Sal Butera

Detail Information

Publications8

  1. doi request reprint Evaluation of the lymphocyte trafficking drug FTY720 in SHIVSF162P3-infected rhesus macaques
    Ellen N Kersh
    Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Antimicrob Chemother 63:758-62. 2009
    ..We address here whether therapeutic use of FTY720 in simian human immunodeficiency virus (SHIV)-infected rhesus macaques could also decrease viraemia...
  2. doi request reprint Repeated rectal SHIVSF162P3 exposures do not consistently induce sustained T cell responses prior to systemic infection in the repeat-low dose preclinical macaque model
    Ellen N Kersh
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    AIDS Res Hum Retroviruses 25:905-17. 2009
    ..Our results provide further insights into the repeat exposure macaque model. We find that this model can be used for testing biomedical prevention strategies without concern of eliciting a systemic vaccination effect...
  3. pmc Reduced inflammation and CD4 loss in acute SHIV infection during oral pre-exposure prophylaxis
    Ellen N Kersh
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Infect Dis 206:770-9. 2012
    ..We addressed the hypothesis that SHIV(SF162P3) infection despite active PrEP results in altered early immune parameters, compared with untreated infection...
  4. pmc Susceptibility to repeated, low-dose, rectal SHIVSF162P3 challenge is independent of TRIM5 genotype in rhesus macaques
    Katherine Butler
    Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    AIDS Res Hum Retroviruses 29:1091-4. 2013
    ..The finding that TRIM5 alleles do not restrict mucosal infection or ensuing replication rates suggests that SHIVSF162P3 is indeed suitable for RLD experimentation...
  5. doi request reprint Resistance to Simian HIV infection is associated with high plasma interleukin-8, RANTES and Eotaxin in a macaque model of repeated virus challenges
    Nattawan Promadej-Lanier
    From the Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Acquir Immune Defic Syndr 53:574-81. 2010
    ..Future direct evaluation of these or other factors in the animal model may be beneficial for developing new immunomodulation strategies for HIV prevention...
  6. doi request reprint Short communication: no evidence of occult SHIV infection as demonstrated by CD8+ cell depletion after chemoprophylaxis-induced protection from mucosal infection in rhesus macaques
    Ellen N Kersh
    Division of HIV AIDS Prevention, NCHHSTP, CCID, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    AIDS Res Hum Retroviruses 24:543-6. 2008
    ..These data provide important information for PrEP usage to prevent HIV transmission, and fully support the continued pursuit of PrEP prevention measures in humans...
  7. pmc T cell chemo-vaccination effects after repeated mucosal SHIV exposures and oral pre-exposure prophylaxis
    Ellen N Kersh
    Division of HIV AIDS Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America
    PLoS ONE 6:e19295. 2011
    ..Our findings highlight the importance of monitoring these responses in clinical PrEP trials and suggest that a combination of vaccines and PrEP potentially might enhance efficacy...
  8. doi request reprint High susceptibility to repeated, low-dose, vaginal SHIV exposure late in the luteal phase of the menstrual cycle of pigtail macaques
    Sundaram A Vishwanathan
    Division of HIV AIDS Prevention, CDC, Atlanta, GA 30329, USA
    J Acquir Immune Defic Syndr 57:261-4. 2011
    ..Our data support the findings of higher susceptibility to HIV in women during progesterone-dominated periods including pregnancy and contraceptive use...